Brian Hannasch
Brian Hannasch's purchase track record
How the stock did after each of Brian Hannasch's open-market purchases, measured from the purchase date. Several fills within a week count as one purchase.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 5/29/2026 | AZO | $493K | +1.0% | pending | — |
| 2/11/2026 | NRXS | $383K | +70.1% | +34.8% | +11.6% |
| 12/18/2025 | AZO | $499K | -2.5% | -10.6% | +10.7% |
| 7/1/2025 | NRXS | $800K | +29.4% | +89.5% | +11.3% |
| 4/21/2025 | NRXS | $31K | +52.1% | +105.0% | +30.6% |
| 5/26/2022 | AZO | $253K | +9.6% | +26.3% | -0.8% |
| 3/3/2022 | AZO | $500K | +9.3% | +13.8% | -9.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
September 29, 2026
NeurAxis Names Craig Blanchard CCO to Drive Commercial Growth. NeurAxis has appointed Craig Blanchard as chief commercial officer to lead the next phase of commercial growth. The move signals the company’s focus on expanding market reach and accelerating product commercialization. Blanchard’s experience is expected to help the firm move from development to broader market adoption.
Transaction History
| AZO | ▲ Buy | Open Market | 165 | $493K | 5/29/2026 | View on chart |
| NRXS | ▲ Buy | Open Market | 40,000 | $197K | 2/12/2026 | View on chart |
| NRXS | ▲ Buy | Open Market | 40,000 | $186K | 2/11/2026 | View on chart |
| AZO | ▲ Buy | Grant | 93 | $0 | 1/1/2026 | View on chart |
| AZO | ▲ Buy | Open Market | 147 | $499K | 12/18/2025 | View on chart |
| NRXS | ▲ Buy | Open Market | 355,556 | $800K | 7/1/2025 | View on chart |
| NRXS | ▲ Buy | Open Market | 18,065 | $31K | 4/21/2025 | View on chart |
| AZO | ▲ Buy | Grant | 95 | $0 | 1/1/2025 | View on chart |
| NRXS | ▲ Buy | Grant | 75,000 | $0 | 2/20/2024 | View on chart |
| NRXS | ▼ Sell | Other | 150,000 | $0 | 2/6/2024 | View on chart |
| AZO | ▲ Buy | Grant | 104 | $0 | 1/1/2024 | View on chart |
| NRXS | ▼ Sell | Open Market | 76 | $198 | 12/28/2023 | View on chart |
| NRXS | ▼ Sell | Other | 40,000 | $200 | 12/28/2023 | View on chart |
| AZO | ▲ Buy | Grant | 103 | $0 | 1/1/2023 | View on chart |
| AZO | ▲ Buy | Open Market | 133 | $253K | 5/26/2022 | View on chart |
| AZO | ▲ Buy | Open Market | 266 | $500K | 3/3/2022 | View on chart |
| AZO | ▲ Buy | Grant | 113 | $212K | 3/2/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
AutoZone Shares Rise as Rep Sells $65K, Director Steps Down
AutoZone shares climbed while the broader market fell, helped by a recent sale of up to $65,000 by a member of the House of Representatives. The company also saw a notable change in leadership as Director Claire McDonough announced she will not seek reelection after taking a new executive role. Whale activity in the sector added to the trading volume, and analysts continue to view the stock as a long‑term holding for some investors.
AutoZone Shares Rise as Rep Sells $65K, Director Steps Down. AutoZone shares climbed while the broader market fell, helped by a recent sale of up to $65,000 by a member of the House of Representatives. The company also saw a notable change in leadership as Director Claire McDonough announced she will not seek reelection after taking a new executive role. Whale activity in the sector added to the trading volume, and analysts continue to view the stock as a long‑term holding for some investors.